03/08/2019
5:08 AM | Catalyst Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) |  |
03/07/2019
3:11 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2019
8:49 AM | BARR WAYNE JR (Filed by)
Catalyst Biosciences (Subject)
| Form SC 13G
| |
02/14/2019
11:15 PM | Catalyst Biosciences (Filer)
| Form EFFECT
| |
02/14/2019
8:53 PM | Catalyst Biosciences (Issuer)
Levy Howard (Reporting)
| Form 4/A
| |
02/14/2019
1:51 PM | Catalyst Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019
10:51 AM | Catalyst Biosciences (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G
| |
02/13/2019
6:19 PM | Catalyst Biosciences (Issuer)
Payne Fletcher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
4:01 PM | Catalyst Biosciences (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
4:00 PM | Catalyst Biosciences (Issuer)
Levy Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2019
12:38 PM | Catalyst Biosciences (Subject)
JFL Capital Management, LLC (Filed by)
| Form SC 13G/A
| |
01/28/2019
5:58 PM | Catalyst Biosciences (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2019
5:56 PM | Catalyst Biosciences (Issuer)
Payne Fletcher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2019
5:54 PM | Catalyst Biosciences (Issuer)
Levy Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2019
3:50 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
4:45 PM | Catalyst Biosciences (Issuer)
Williams Eddie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
4:44 PM | Catalyst Biosciences (Issuer)
LAWLOR AUGUSTINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
4:44 PM | Catalyst Biosciences (Issuer)
Hunt Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
4:43 PM | Catalyst Biosciences (Issuer)
DESOUZA ERROL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
3:08 PM | Catalyst Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/18/2018
3:50 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2018
4:01 PM | Catalyst Biosciences (Issuer)
Levy Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
4:56 PM | Catalyst Biosciences (Issuer)
Levy Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
4:01 PM | Catalyst Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/06/2018
8:41 PM | Catalyst Biosciences (Issuer)
HILL STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2018
3:11 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2018
4:25 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2018
4:01 PM | Catalyst Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2018
11:17 AM | Catalyst Biosciences (Subject)
JFL Capital Management, LLC (Filed by)
| Form SC 13G
| |
08/01/2018
4:48 PM | Catalyst Biosciences (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2018
4:48 PM | Catalyst Biosciences (Issuer)
Payne Fletcher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2018
4:47 PM | Catalyst Biosciences (Issuer)
Levy Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2018
9:49 AM | Catalyst Biosciences (Issuer)
JFL Capital Management, LLC (Reporting)
| Form 3/A
| |
07/27/2018
8:54 AM | Catalyst Biosciences (Issuer)
JFL Capital Management, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2018
3:28 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2018
8:02 AM | Catalyst Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/25/2018
3:12 PM | Catalyst Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G
| |
06/21/2018
3:55 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2018
4:57 PM | Catalyst Biosciences (Issuer)
Williams Eddie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:56 PM | Catalyst Biosciences (Issuer)
Richard John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:53 PM | Catalyst Biosciences (Issuer)
LAWLOR AUGUSTINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:53 PM | Catalyst Biosciences (Issuer)
Hunt Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:52 PM | Catalyst Biosciences (Issuer)
HILL STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
4:52 PM | Catalyst Biosciences (Issuer)
DESOUZA ERROL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
3:40 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2018
9:35 AM | Catalyst Biosciences (Subject)
NEXTHERA CAPITAL LP (Filed by)
| Form SC 13G
| |
05/24/2018
3:59 PM | Catalyst Biosciences (Subject)
NEXTHERA CAPITAL LP (Filed by)
| Form SC 13G/A
| |
05/11/2018
3:04 PM | Catalyst Biosciences (Filer)
| Form DEF 14A
| |
05/03/2018
4:00 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2018
3:50 PM | Catalyst Biosciences (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
04/13/2018
3:36 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2018
7:00 PM | Catalyst Biosciences (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/06/2018
4:03 PM | Catalyst Biosciences (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2018
3:11 PM | Catalyst Biosciences (Issuer)
Payne Fletcher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2018
3:12 PM | Catalyst Biosciences (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4/A
| |
03/19/2018
4:06 PM | Catalyst Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2018
4:18 PM | Catalyst Biosciences (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2018
3:31 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2018
3:04 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2018
3:36 PM | Catalyst Biosciences (Issuer)
Richard John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2018
3:33 PM | Catalyst Biosciences (Issuer)
HILL STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2018
3:30 PM | Catalyst Biosciences (Issuer)
DESOUZA ERROL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2018
7:49 PM | Catalyst Biosciences (Subject)
Flynn James E (Filed by)
| Form SC 13G
| |
02/15/2018
7:47 PM | Catalyst Biosciences (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2018
3:06 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2018
10:07 AM | Catalyst Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A
| |
02/14/2018
5:13 AM | Catalyst Biosciences (Filer)
| Form 424B5
| |
02/12/2018
4:20 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2018
4:19 PM | Catalyst Biosciences (Filer)
| Form 424B5
| |
02/12/2018
5:07 AM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2018
1:45 PM | Catalyst Biosciences (Subject)
HealthCare Ventures VIII, L.P. (Filed by)
| Form SC 13D/A
| |
02/09/2018
7:00 AM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2018
11:15 PM | Catalyst Biosciences (Filer)
| Form EFFECT
| |
02/05/2018
8:11 AM | Catalyst Biosciences (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G
| |
01/29/2018
3:30 PM | Catalyst Biosciences (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G
| |
01/22/2018
3:40 PM | Catalyst Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/22/2018
9:02 AM | Catalyst Biosciences (Subject)
JOHNSON & JOHNSON (Filed by)
| Form SC 13G/A
| |
01/18/2018
5:03 PM | Catalyst Biosciences (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2018
3:01 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2018
2:44 PM | Catalyst Biosciences (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2018
2:43 PM | Catalyst Biosciences (Issuer)
Payne Fletcher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2018
2:42 PM | Catalyst Biosciences (Issuer)
Levy Howard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2018
4:00 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2018
5:49 PM | Catalyst Biosciences (Issuer)
Williams Eddie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2018
5:46 PM | Catalyst Biosciences (Issuer)
Williams Eddie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/27/2017
12:30 PM | Catalyst Biosciences (Subject)
NEXTHERA CAPITAL LP (Filed by)
| Form SC 13G
| |
12/22/2017
4:00 PM | Catalyst Biosciences (Issuer)
Richard John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2017
12:01 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2017
5:08 AM | Catalyst Biosciences (Filer)
| Form 424B5
| |
12/19/2017
4:03 PM | Catalyst Biosciences (Filer)
| Form 424B5
| |
12/18/2017
4:02 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2017
4:26 PM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2017
7:30 AM | Catalyst Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
